Abiopharma

🔍 Ricard Corrine D. (Director)

Company: CARLISLE COMPANIES INC (CSL)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 26 shares of Restricted Stock Units (Derivative)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,147.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F2

Footnotes:

• F1: Represents additional restricted stock units acquired as a result of the quarterly dividend declared and paid by the issuer. Each restricted stock unit represents a right to receive one share of the issuer's common stock.
• F2: The restricted stock units were fully vested on the date of grant and the vested shares will be delivered to the reporting person upon the reporting person's termination of service as a director of the issuer.